The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Improving comprehensive genotyping in patients with newly diagnosed non-squamous NSCLC: Results from a prospective trial of a behavioral nudge intervention.
 
Charu Aggarwal
Consulting or Advisory Role - AstraZeneca; BeiGene; Blueprint Genetics; Boehringer Ingelheim; Celgene; Daiichi Sankyo/Astra Zeneca; Eisai; Genentech; Janssen; Lilly; Merck; Pfizer; Sanofi/Regeneron; Shionogi; Turning Point Therapeutics
Speakers' Bureau - AstraZeneca (I); Roche/Genentech (I)
Research Funding - AstraZeneca/MedImmune (Inst); Genentech/Roche (Inst); Incyte (Inst); Macrogenics (Inst); Merck Sharp & Dohme (Inst)
 
Erica L. Carpenter
Honoraria - AstraZeneca; Guardant Health
Consulting or Advisory Role - Bristol-Myers Squibb
Research Funding - AstraZeneca (Inst); Becton Dickinson (Inst); C2i genomics (Inst); Chip Diagnostics (Inst); Janssen (Inst); Merck (Inst); Merck (Inst); Parker Institute for Cancer Immunotherapy (Inst); United Health Group
Patents, Royalties, Other Intellectual Property - Invention disclosure entitled, "Methods and Compositions for Identifying, Diagnosing and Treating Neuroblastoma"; Invention disclosure entitled, "Methods and Compositions for Identifying, Diagnosing and Treating Neuroblastoma"; Invention disclosure entitled, "Methods and Compositions for Treating Neuroblastoma"
Travel, Accommodations, Expenses - AstraZeneca; Foundation Medicine
 
Dylan G. Scholes
No Relationships to Disclose
 
Wei-Ting Hwang
Employment - Janssen (I)
Research Funding - Novartis
 
Tara McWilliams
Stock and Other Ownership Interests - Bayer; Johnson & Johnson/Janssen; Procter & Gamble
 
Aditi Puri Singh
Consulting or Advisory Role - Precision HEOR (I)
 
Lova Sun
Consulting or Advisory Role - HMP; MJH Life Sciences; Regeneron
 
John A. Kosteva
No Relationships to Disclose
 
Michael Robert Costello
No Relationships to Disclose
 
Abigail Doucette
No Relationships to Disclose
 
Peter Edward Gabriel
Travel, Accommodations, Expenses - Varian Medical Systems; Varian Medical Systems
 
Megan Roy
Speakers' Bureau - AstraZeneca
 
Anthony O. Martella
No Relationships to Disclose
 
Jeffrey C. Thompson
Consulting or Advisory Role - AstraZeneca
 
Roger B. Cohen
Honoraria - AstraZeneca
Consulting or Advisory Role - AstraZeneca; Cantargia AB; Coherus Biosciences; Fstar Therapeutics; Heat Biologics; Xencor
Research Funding - AstraZeneca (Inst); Celldex (Inst); Codiak Biosciences (Inst); F-Star Biotechnology (Inst); Genocea Biosciences (Inst); Heat Biologics (Inst); Innate Pharma (Inst); Macrogenics (Inst); Merck (Inst); Xencor (Inst)
 
Corey J. Langer
Honoraria - AstraZeneca; Bristol-Myers Squibb; Genentech/Roche; Lilly/ImClone; Merck; Takeda Science Foundation
Consulting or Advisory Role - Abbott Biotherapeutics; ARIAD; AstraZeneca; Bayer/Onyx; Bristol-Myers Squibb; Cancer Support Community; Celgene; Clarient; Clovis Oncology; Genentech/Roche; Gilead Sciences; Lilly/ImClone; Merck; Novocure; Pfizer; Regeneron; Takeda
Research Funding - Advantagene (Inst); Amgen; Ariad (Inst); AstraZeneca; Celgene (Inst); Clovis Oncology (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Inovio Pharmaceuticals (Inst); Johnson & Johnson/Janssen; Lilly; Merck (Inst); Stem CentRx (Inst); Trizell (Inst)
Other Relationship - Amgen; Lilly; OncoCyte; Peregrine Pharmaceuticals; Synta
 
Lawrence N. Shulman
Research Funding - Celgene (Inst); Independence Blue Cross (Inst)
 
Melina Elpi Marmarelis
Stock and Other Ownership Interests - Bluebird Bio; Gilead Sciences; Johnson & Johnson; Merck; Pfizer; Portola Pharmaceuticals
Honoraria - AstraZeneca; Blueprint Medicines; Blueprint Medicines; Health Advances (I); Janssen Oncology; Novocure; Takeda; Targeted Oncology
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb/Celgene; Ikena Oncology
Research Funding - AstraZeneca (Inst); Lilly (Inst); Trizell (Inst)
Travel, Accommodations, Expenses - Boehringer Ingelheim; Novocure
Other Relationship - Novartis